B-HIL2RA mice (110066) license
Ended Purchase Order Awarded Last action
- Contract number
- 75N91023P00848
- Awardee
-
Biocytogen Boston Corp UEI SN23DNZQQTF9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,000
Award facts
- Contract value 100% obligated
- $24,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 513210 Software Publishers
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Wakefield, MA 01880, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $24,000 purchase order to Biocytogen Boston Corporation for B-HIL2RA MICE (110066) LICENSE. Under this firm fixed price contract, Biocytogen Boston will deliver a license for the specified mice to support the NIH NCI's cancer research efforts. No major subcontractors or set aside designations were identified. The one month period of performance from September 13, 2023 through October 12, 2023 indicates this non-R&D contract provides a short-term license to further the NIH NCI's goal of finding new and better ways to prevent and treat cancer.
Quick answers
Who was awarded contract 75N91023P00848?
75N91023P00848 was awarded to Biocytogen Boston Corp by National Cancer Institute (National Institutes of Health) on September 13, 2023.
How much is contract 75N91023P00848 worth?
The government has obligated $24,000 on 75N91023P00848.
Was contract 75N91023P00848 competed?
The extent of competition for 75N91023P00848 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award